Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer

计划入组 12 人 · 首次发布于 2020 年 5 月 4 日

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

计划入组 12 人 · 首次发布于 2018 年 11 月 29 日

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

计划入组 16 人 · 首次发布于 2016 年 11 月 1 日

IRX-4647

IRX-2

IRX-010

IRX Therapeutics, Inc.

United States

InhaleRx Ltd

Fox Ira

Israel

InhaleRx Secures Funding for Phase 2 Trials of IRX-211 in Breakthrough Cancer Pain

InhaleRx Secures $38.5M Funding to Advance Inhaled Therapies for Cancer Pain and Panic Disorder

InhaleRx Secures $38.5 Million Funding to Advance Novel Inhaled Therapies for Cancer Pain and Panic Disorder